- $8.07bn
- $10.18bn
- BRL23.83bn
- 100
- 87
- 86
- 100
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,377 | 17,268 | 18,058 | 21,531 | 23,834 |
Cost of Revenue | |||||
Gross Profit | 9,943 | 9,271 | 7,183 | 7,798 | 9,301 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12,790 | 14,453 | 14,302 | 18,371 | 19,117 |
Operating Profit | 4,587 | 2,815 | 3,756 | 3,160 | 4,717 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,775 | 2,008 | 3,103 | 1,721 | 3,184 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,860 | 1,844 | 2,957 | 1,671 | 2,837 |
Net Income Before Extraordinary Items | |||||
Net Income | 3,860 | 1,844 | 2,957 | 1,671 | 2,837 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3,622 | 1,844 | 2,957 | 1,671 | 2,837 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.5 | 1.03 | 1.97 | 0.832 | 1.47 |
Dividends per Share |